InvestorsHub Logo
Followers 11
Posts 1565
Boards Moderated 0
Alias Born 09/19/2006

Re: None

Friday, 11/15/2019 1:48:12 PM

Friday, November 15, 2019 1:48:12 PM

Post# of 6390
Regarding PN's earnings call the information he now provides is excellent. I am excited about BP1003's status as the only drug with the ability to penetrate the stroma of a pancreatic cancer tumor. If this result holds up patient trials I see BP1003 as a game changer drug for this company.

I wish he would provide us with more information on this subject.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent BPTH News